Vaxart, Inc.
Vaxart, Inc. (VXRT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VXRT · as of Jun 9, 2026
Key Statistics
Explore Vaxart, Inc. Data
vxrt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The VXRT analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing +234.06% upside from the current price of $0.60.
Competitors & Peers
vxrt competitorsVXRT
ACRV
CAMP
CBUS
FBIO
IMUXStock Performance
Full HistoryAbout Vaxart, Inc.
Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company l…
what is vaxart, inc. · vxrt stock overview · vaxart, inc. company profile · who is vaxart, inc. ceo · vxrt NASDAQ · vaxart, inc. headquarters · vaxart, inc. business segments
About Stock Overview & Key Data
Vaxart, Inc. (VXRT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 11, 1981. As of the latest trading session, VXRT stock price is $0.60, with a market capitalization of $144.9M. The stock has returned +50.77% over the past 12 months and +71.06% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Vaxart, Inc. stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2025, Vaxart, Inc. reported revenue of $237.3M and net income of $16.3M. For detailed data — including Vaxart, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Vaxart, Inc. (VXRT) stock price is $0.60. The stock is traded on NASDAQ under the ticker symbol VXRT. The 52-week range is $0.26 – $0.84.